-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EmhcLBMcLp6qYIxZjd1WL4AjXx9CTijex83tPeV3z3jkMe8LUsqy5eoVQWLYBDX5 wagtjdq3GUV1g6yvCXFmLA== 0001219033-11-000001.txt : 20110216 0001219033-11-000001.hdr.sgml : 20110216 20110216192229 ACCESSION NUMBER: 0001219033-11-000001 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101231 FILED AS OF DATE: 20110216 DATE AS OF CHANGE: 20110216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gruber Joerg CENTRAL INDEX KEY: 0001397461 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20580 FILM NUMBER: 11618981 MAIL ADDRESS: STREET 1: C/O SYNTHEMED, INC. STREET 2: 200 MIDDLESEX ESSEX TURNPIKE CITY: ISELIN STATE: NJ ZIP: 08830 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SyntheMed, Inc. CENTRAL INDEX KEY: 0000889428 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 141745197 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 MIDDLESEX ESSEX TURNPIKE, SUITE 210 CITY: ISELIN STATE: NJ ZIP: 08830 BUSINESS PHONE: 7324041117 MAIL ADDRESS: STREET 1: 200 MIDDLESEX ESSEX TURNPIKE, SUITE 210 CITY: ISELIN STATE: NJ ZIP: 08830 FORMER COMPANY: FORMER CONFORMED NAME: LIFE MEDICAL SCIENCES INC DATE OF NAME CHANGE: 19930328 5 1 primary_doc.xml PRIMARY DOCUMENT X0303 5 2010-12-31 0 0 1 0000889428 SyntheMed, Inc. symd 0001397461 Gruber Joerg C/O SYNTHEMED, INC. 200 MIDDLESEX ESSEX TURNPIKE ISELIN NJ 08830 1 0 0 0 Common Stock 2010-03-31 4 A 0 L 24375 0.1 A 3650904 D Common Stock 2010-06-30 4 A 0 L 34091 0.11 A 3650904 D Common Stock 2010-09-30 4 A 0 L 93750 0.04 A 3650904 D Common Stock 2010-12-31 4 A 0 L 18750 0.2 A 3650904 D Reflects the portion of the reporting person's quarterly board fees for the quarter ended on the referenced transaction date which, in accordance with approval by the Board of Directors, is payable in shares of common stock, based on the fair market value of the shares on the last trading day of the quarter, as reflected by the closing price on that date: $.10 on March 31, $.11 on June 30, $.04 on September 30 and $.20 on December 31. Joerg Gruber, by Keith Moskowitz, attorney-in-fact 2011-02-16 -----END PRIVACY-ENHANCED MESSAGE-----